Genomic fragment that encompasses RNaseZ (including its endogenous regulatory sequences). A F155L amino acid substitution has been introduced into the coding sequence. This change is equivalent to a F154L change in the orthologous human ELAC2 gene, a variant associated with cardiomyopathy. The coding sequence is tagged at C-terminal end with Tag:V5.
T10309201C
F155L | RNaseZ-PB
F155L
Mutation in analagous codon in human ELAC2 implicated in cardiomyopathy associated with combined oxidative phosphorylation deficiency 17; mutation carried on in vitro construct; site of nucleotide substitution in fly gene and specific disease association inferred by FlyBase curator based on reported amino acid change. The nucleotide change was reported as C463T, a presumed typo for T463C.
RNaseZED24/RNaseZED24 individuals bearing 1 or two copies of RNaseZHCM1.Tag:V5 show a decreased climbing ability, as compared to controls; homozygotes bearing 1 copy of RNaseZHCM1.Tag:V5 show a thickened heart wall at the larval and adult stages; end-diastolic area and end-systolic area are increased in larval and adult hearts; homozygotes bearing 1 copy of RNaseZHCM1.Tag:V5 show decreased fractional shortening in the adult heart. Muscle cells show increased number of nuclei with increased ploidy.
FBal0369460:, RNaseZED24 is partially rescued by RNaseZHCM1.Tag:V5/RNaseZHCM1.Tag:V5
RNaseZHCM1.Tag:V5 partially rescues RNaseZED24
RNaseZHCM1.Tag:V5/RNaseZHCM1.Tag:V5 partially rescues FBal0369460:, RNaseZED24